HSA approves first commercial CAR-T therapy by Novartis
HSA approves first commercial CAR-T therapy by Novartis 10 March 2021 | News Novartis receives approval for Kymriah® (tisagenlecleucel) in Southeast Asia to treat two life-threatening cancers that have limited treatment options and historically poor outcomes
Photo Credit: Freepik
Novartis has announced that Singapore Health Sciences Authority (HSA) has approved Kymriah (tisagenlecleucel) as the first commercial chimeric antigen receptor T-cell (CAR-T) therapy in Singapore under the new cell, tissue and gene therapy products (CTGTP) regulatory framework. Kymriah, a CD19-directed genetically modified autologous T-cell immunocellular therapy, is approved to treat two life-threatening cancers that have limited treatment options and historically poor outcomes, addressing the critical need for new therapies for these patients.
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Moderna Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Updates
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
February 17, 2021
As it stands, Covid-19 has infected more than 110 million people and taken the lives of more than two million globally. There is no sign of this pandemic slowing down. But hope remains. The vaccine, once thought to be a few years away, is here. But some remain cautious.
Maybe you are just unsure or need some assurance to get vaccinated in this fight against a global pandemic. Well, here you go. These are five myth-busters you need to read today.
1. There is no virus in the mRNA vaccines
Unlike traditional vaccines for measles or chicken pox, the Covid-19 mRNA vaccines do not contain live virus.
Telehealth Ventilators Worth More Than RM2 Million to be Donated to Malaysian Hospitals to Treat COVID-19 Patients in Intensive Care
February 16, 2021 20:00 ET | Source: Advanced MedTech Advanced MedTech
Donation is part of the Billion Breath Project and will benefit thousands of severely affected COVID-19 patients in Southeast and South Asia
Alpha ventilator is the world’s first telehealth ventilator that facilitates the remote management of patients with severe breathing difficulties
The first five Alpha units were donated today to Hospital Selayang in Selangor, where COVID-19 cases have spiked in recent weeks
SINGAPORE, Feb. 17, 2021 (GLOBE NEWSWIRE) Advanced MedTech Holdings (AMTH), a global medical technology leader headquartered in Singapore, have announced a donation of up to RM2 million worth of Alpha ventilators to hospitals in Malaysia.